Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Muscle Nerve. 2018 Nov 26;59(2):201–207. doi: 10.1002/mus.26335

Figure 2. Survival curves and mitochondrial biomarkers.

Figure 2.

A) There was no difference in survival between the rasagiline, placebo, and historical controls (Log-rank test Chi Squared=0.41, p=0.81). Vertical hash lines indicate withdrawals (dropouts). B) We found no treatment-related difference in the 6 months change in blood biomarkers (JC-1 above, ORAC below) which showed drug-target engagement in our prior study.